Gene · 54
Papers2,683
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,683
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inflammation- and metabolism-related transcriptional features in murine lupus nephritis: A single-cell kidney reanalysis. | Transl Oncol | 2026 | 42826657 | PubTator, text mining | PubMed |
| Efficacy of sequential romosozumab-denosumab therapy in patients on hemodialysis: association with bone mineral density improvement and TRACP-5b rebound. | Osteoporos Int | 2026 | 42821093 | PubTator, text mining | PubMed |
| Combined baseline P1NP and TRAcP5b classification predicts differential bone mineral density response to romosozumab: A retrospective cohort study of 287 postmenopausal women. | J Clin Densitom | 2026 | 42809930 | PubTator, text mining | PubMed |
| Gut Microbiota and SCFA Changes After Alendronate-Calcitriol Therapy in Postmenopausal Osteoporosis. | Int J Womens Health | 2026 | 42801217 | PubTator, text mining | PubMed |
| Equivalent Twelve-Month Bone Mineral Density Response to Romosozumab in Patients Aged ≥ 85 Years and < 85 Years: A Multi-center Real-World Cohort Study (n = 417) from Northern Japan. | Calcif Tissue Int | 2026 | 42789080 | PubTator, text mining | PubMed |
| ACP5-positive macrophages contribute to cerebral oedema and neuroinflammation after traumatic brain injury. | Clin Transl Med | 2026 | 42786914 | PubTator, text mining | PubMed |
| Correlation analysis of serum CCL3, TRACP-5b, and sclerostin with the prognosis of multiple myeloma patients. | J Med Biochem | 2026 | 42781632 | PubTator, text mining | PubMed |
| Correlation analysis of PGC-1β, HIF-1α and RETN with the degree of joint destruction in gouty arthritis. | J Med Biochem | 2026 | 42780816 | PubTator, text mining | PubMed |
| Integrative transcriptomic analysis identifies ACP5 and FBLN5 as candidate shared transcriptomic signatures between pulpitis and carotid plaque rupture. | Sci Rep | 2026 | 42744917 | PubTator, text mining | PubMed |
| Protective effects and mechanisms of puerarin in ovariectomized animal models of osteoporosis: a systematic review and meta-analysis of preclinical studies. | Front Physiol | 2026 | 42724066 | PubTator, text mining | PubMed |
| A dual-action humanized DKK-1 antibody that activates the Wnt/β-catenin signaling pathway and inhibits the RANKL signaling pathway for osteoporosis therapy. | Front Immunol | 2026 | 42723851 | PubTator, text mining | PubMed |
| Bone turnover markers associated with cognitive dysfunction in patients undergoing hemodialysis: a cross-sectional study. | JBMR Plus | 2026 | 42689211 | PubTator, text mining | PubMed |
| Comparative effects of local denosumab and recombinant human growth hormone on periodontal remodeling in experimental periodontitis. | J Stomatol Oral Maxillofac Surg | 2026 | 42624464 | PubTator, text mining | PubMed |
| Bone Turnover Markers, DXA and Mineral Metabolism in Long-Term Kidney Transplant Recipients: A Cross-Sectional Comparative Study. | J Clin Med | 2026 | 42590077 | PubTator, text mining | PubMed |
| Clinical implications of serum GDF15 propeptide as a biomarker for bone metastasis across common solid tumors: a real-world multi-institutional study. | Biomark Res | 2026 | 42587303 | PubTator, text mining | PubMed |
| Biodegradation of TDCPP by Chlorella pyrenoidosa: Kinetic, metabolic, and molecular mechanistic insights. | J Hazard Mater | 2026 | 42585951 | PubTator, text mining | PubMed |
| IOF-IFCC international survey of global laboratory practices for bone status indices. | Clin Chem Lab Med | 2026 | 42560324 | PubTator, text mining | PubMed |
| Sequential therapy following romosozumab: real-world comparison of denosumab and bisphosphonates with 2-year follow-up. | J Clin Densitom | 2026 | 42546512 | PubTator, text mining | PubMed |
| Dissecting the Transcriptomic Profile of CD163+ Macrophages in Hepatocellular Carcinoma with VETC+ Angiogenesis Provides Potential Targets of Treatment. | Liver Cancer | 2026 | 42524682 | PubTator, text mining | PubMed |
| Targeting NAE1 suppresses osteoclastogenesis via dual regulation of ferritinophagy and ACSL3-mediated ferroptosis. | Autophagy | 2026 | 42495964 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54/papers